• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在具有胶质母细胞瘤的完全免疫功能的动物中,常规放疗和 FLASH 后均具有长期抗肿瘤作用。

Long-term anti-tumor effects following both conventional radiotherapy and FLASH in fully immunocompetent animals with glioblastoma.

机构信息

The Rausing Laboratory, Division of Neurosurgery, Department of Clinical Sciences, Lund University, Lund, Sweden.

Medical Radiation Physics, Department of Clinical Sciences, Lund University, Lund, Sweden.

出版信息

Sci Rep. 2022 Jul 19;12(1):12285. doi: 10.1038/s41598-022-16612-6.

DOI:10.1038/s41598-022-16612-6
PMID:35853933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9296533/
Abstract

Radiotherapy can induce an immunological response. One limiting factor is side effects on normal tissue. Using FLASH radiotherapy, side effects could possibly be reduced. The efficacy of FLASH in relation to conventional radiotherapy (CONV-RT) has not been extensively explored in fully immunocompetent animals. Fully immunocompetent Fischer 344 rats were inoculated with NS1 glioblastoma cells subcutaneously or intracranially. Radiotherapy was delivered with FLASH or CONV-RT at 8 Gy × 2 (subcutaneous tumors) and 12.5 Gy × 2 (intracranial tumors). Cured animals were re-challenged in order to explore long-term anti-tumor immunity. Serum analytes and gene expression were explored. The majority of animals with subcutaneous tumors were cured when treated with FLASH or CONV-RT at 8 Gy × 2. Cured animals could reject tumor re-challenge. TIMP-1 in serum was reduced in animals treated with FLASH 8 Gy × 2 compared to control animals. Animals with intracranial tumors survived longer when treated with FLASH or CONV-RT at 12.5 Gy × 2, but cure was not reached. CONV-RT and FLASH were equally effective in fully immunocompetent animals with glioblastoma. Radiotherapy was highly efficient in the subcutaneous setting, leading to cure and long-term immunity in the majority of the animals.

摘要

放射治疗可以诱导免疫反应。一个限制因素是对正常组织的副作用。使用 FLASH 放射治疗,副作用可能会减少。FLASH 在完全免疫功能正常的动物中与常规放射治疗(CONV-RT)的疗效尚未得到广泛探索。完全免疫功能正常的 Fischer 344 大鼠皮下或颅内接种 NS1 神经胶质瘤细胞。FLASH 或 CONV-RT 以 8 Gy×2(皮下肿瘤)和 12.5 Gy×2(颅内肿瘤)进行放射治疗。治愈的动物被重新挑战,以探索长期抗肿瘤免疫。探索血清分析物和基因表达。当用 FLASH 或 CONV-RT 以 8 Gy×2 治疗时,大多数患有皮下肿瘤的动物被治愈。治愈的动物可以拒绝肿瘤再挑战。与对照动物相比,用 FLASH 8 Gy×2 治疗的动物血清中 TIMP-1 减少。当用 FLASH 或 CONV-RT 以 12.5 Gy×2 治疗时,颅内肿瘤的动物存活时间更长,但未达到治愈。FLASH 和 CONV-RT 在完全免疫功能正常的神经胶质瘤动物中同样有效。放射治疗在皮下环境中非常有效,导致大多数动物治愈和长期免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/d16ac7d809b8/41598_2022_16612_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/a84796234cd3/41598_2022_16612_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/dea32c166cf6/41598_2022_16612_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/1af2ec2dafa0/41598_2022_16612_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/e929b063528a/41598_2022_16612_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/29114e2bf003/41598_2022_16612_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/66e144eb8f92/41598_2022_16612_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/7fa0b5edd033/41598_2022_16612_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/d16ac7d809b8/41598_2022_16612_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/a84796234cd3/41598_2022_16612_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/dea32c166cf6/41598_2022_16612_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/1af2ec2dafa0/41598_2022_16612_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/e929b063528a/41598_2022_16612_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/29114e2bf003/41598_2022_16612_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/66e144eb8f92/41598_2022_16612_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/7fa0b5edd033/41598_2022_16612_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec3/9296533/d16ac7d809b8/41598_2022_16612_Fig8_HTML.jpg

相似文献

1
Long-term anti-tumor effects following both conventional radiotherapy and FLASH in fully immunocompetent animals with glioblastoma.在具有胶质母细胞瘤的完全免疫功能的动物中,常规放疗和 FLASH 后均具有长期抗肿瘤作用。
Sci Rep. 2022 Jul 19;12(1):12285. doi: 10.1038/s41598-022-16612-6.
2
Comparable survival in rats with intracranial glioblastoma irradiated with single-fraction conventional radiotherapy or FLASH radiotherapy.接受单次分割常规放疗或FLASH放疗的颅内胶质母细胞瘤大鼠的生存情况相当。
Front Oncol. 2024 Jan 16;13:1309174. doi: 10.3389/fonc.2023.1309174. eCollection 2023.
3
Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model.在具有免疫活性的大鼠胶质瘤模型中,低分割FLASH放疗与传统放疗的长期肿瘤控制效果相当。
Adv Radiat Oncol. 2022 Jul 2;7(6):101011. doi: 10.1016/j.adro.2022.101011. eCollection 2022 Nov-Dec.
4
Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy.阐明幼年小鼠接受低分割放射治疗时 FLASH 效应的神经机制。
Neuro Oncol. 2023 May 4;25(5):927-939. doi: 10.1093/neuonc/noac248.
5
Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.FLASH-RT 低分割治疗作为一种有效治疗胶质母细胞瘤的方法,可以减少小鼠的神经认知副作用。
Clin Cancer Res. 2021 Feb 1;27(3):775-784. doi: 10.1158/1078-0432.CCR-20-0894. Epub 2020 Oct 15.
6
Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses.FLASH 或常规剂量率照射的抗肿瘤作用均涉及等效免疫反应。
Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):1110-1122. doi: 10.1016/j.ijrobp.2023.10.031. Epub 2023 Nov 10.
7
Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies.MV X射线FLASH放疗与传统放疗之间肿瘤内及局部免疫反应的比较。
Clin Transl Radiat Oncol. 2022 Nov 9;38:138-146. doi: 10.1016/j.ctro.2022.11.005. eCollection 2023 Jan.
8
Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.局部皮肤鳞状细胞癌或基底细胞癌患者FLASH放疗与传统放疗的随机II期选择试验:研究方案
Clin Transl Radiat Oncol. 2024 Feb 8;45:100743. doi: 10.1016/j.ctro.2024.100743. eCollection 2024 Mar.
9
Comparison of Tumor Control and Skin Damage in a Mouse Model after Ultra-High Dose Rate Irradiation and Conventional Irradiation.超高剂量率照射与常规照射后小鼠模型肿瘤控制与皮肤损伤的比较。
Radiat Res. 2023 Sep 1;200(3):223-231. doi: 10.1667/RADE-23-00057.
10
Combined anti-C1-INH and radiotherapy against glioblastoma.联合抗 C1-INH 与放疗治疗脑胶质瘤。
BMC Cancer. 2023 Jan 30;23(1):106. doi: 10.1186/s12885-023-10583-1.

引用本文的文献

1
FLASH radiotherapy: bridging revolutionary mechanisms and clinical frontiers in cancer treatment - a narrative review.FLASH放疗:连接癌症治疗中的革命性机制与临床前沿——一篇叙述性综述
Ewha Med J. 2024 Oct;47(4):e54. doi: 10.12771/emj.2024.e54. Epub 2024 Oct 31.
2
The evolution of FLASH radiotherapy: a bibliometric analysis.FLASH放疗的发展:一项文献计量学分析
Front Oncol. 2025 May 15;15:1580848. doi: 10.3389/fonc.2025.1580848. eCollection 2025.
3
Reinventing Radiobiology in the Light of FLASH Radiotherapy.基于FLASH放射治疗重塑放射生物学。

本文引用的文献

1
CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas.CD74与胶质瘤中的恶性肿瘤及免疫微环境相关。
Front Mol Biosci. 2021 Sep 1;8:706949. doi: 10.3389/fmolb.2021.706949. eCollection 2021.
2
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?新诊断胶质母细胞瘤随机对照III期试验的真实世界有效性:试验结果适用于谁?
Neurooncol Adv. 2021 Feb 26;3(1):vdab008. doi: 10.1093/noajnl/vdab008. eCollection 2021 Jan-Dec.
3
Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.
Annu Rev Cancer Biol. 2023 Apr;7:1-21. doi: 10.1146/annurev-cancerbio-061421-022217. Epub 2023 Jan 11.
4
FLASH Radiotherapy: Mechanisms of Biological Effects and the Therapeutic Potential in Cancer.FLASH 放疗:生物学效应机制及在癌症治疗中的潜力。
Biomolecules. 2024 Jun 25;14(7):754. doi: 10.3390/biom14070754.
5
The FLASH effect-an evaluation of preclinical studies of ultra-high dose rate radiotherapy.FLASH效应——超高剂量率放射治疗的临床前研究评估
Front Oncol. 2024 Apr 22;14:1340190. doi: 10.3389/fonc.2024.1340190. eCollection 2024.
6
Electron FLASH radiotherapy in vivo studies. A systematic review.电子FLASH放射治疗的体内研究。系统综述。
Front Oncol. 2024 Apr 9;14:1373453. doi: 10.3389/fonc.2024.1373453. eCollection 2024.
7
FLASH Radiotherapy: Expectations, Challenges, and Current Knowledge.FLASH放疗:期望、挑战与当前认知
Int J Mol Sci. 2024 Feb 22;25(5):2546. doi: 10.3390/ijms25052546.
8
Comparable survival in rats with intracranial glioblastoma irradiated with single-fraction conventional radiotherapy or FLASH radiotherapy.接受单次分割常规放疗或FLASH放疗的颅内胶质母细胞瘤大鼠的生存情况相当。
Front Oncol. 2024 Jan 16;13:1309174. doi: 10.3389/fonc.2023.1309174. eCollection 2023.
9
Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses.FLASH 或常规剂量率照射的抗肿瘤作用均涉及等效免疫反应。
Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):1110-1122. doi: 10.1016/j.ijrobp.2023.10.031. Epub 2023 Nov 10.
10
Comparison of Tumor Control and Skin Damage in a Mouse Model after Ultra-High Dose Rate Irradiation and Conventional Irradiation.超高剂量率照射与常规照射后小鼠模型肿瘤控制与皮肤损伤的比较。
Radiat Res. 2023 Sep 1;200(3):223-231. doi: 10.1667/RADE-23-00057.
FLASH-RT 低分割治疗作为一种有效治疗胶质母细胞瘤的方法,可以减少小鼠的神经认知副作用。
Clin Cancer Res. 2021 Feb 1;27(3):775-784. doi: 10.1158/1078-0432.CCR-20-0894. Epub 2020 Oct 15.
4
FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy.FLASH 放疗:质子束治疗的现有知识和未来见解。
Int J Mol Sci. 2020 Sep 5;21(18):6492. doi: 10.3390/ijms21186492.
5
Radioresistance in Glioblastoma and the Development of Radiosensitizers.胶质母细胞瘤中的放射抗性与放射增敏剂的研发
Cancers (Basel). 2020 Sep 3;12(9):2511. doi: 10.3390/cancers12092511.
6
Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair.MIF 细胞因子/CD74 受体通路在保护免受损伤和促进修复中的作用。
Front Immunol. 2020 Jun 23;11:1273. doi: 10.3389/fimmu.2020.01273. eCollection 2020.
7
Increased effect of two-fraction radiotherapy in conjunction with IDO1 inhibition in experimental glioblastoma.两分割放疗联合 IDO1 抑制在实验性脑胶质母细胞瘤中的增效作用。
PLoS One. 2020 May 29;15(5):e0233617. doi: 10.1371/journal.pone.0233617. eCollection 2020.
8
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.成人脑胶质母细胞瘤:神经肿瘤学会(SNO)和欧洲神经肿瘤学会(EANO)关于当前管理和未来方向的共识综述。
Neuro Oncol. 2020 Aug 17;22(8):1073-1113. doi: 10.1093/neuonc/noaa106.
9
Growth pattern of experimental glioblastoma.实验性脑胶质瘤的生长模式。
Histol Histopathol. 2020 Aug;35(8):871-886. doi: 10.14670/HH-18-207. Epub 2020 Feb 5.
10
Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?超高剂量率(FLASH)放疗:万灵药还是金玉其外败絮其中?
Front Oncol. 2020 Jan 17;9:1563. doi: 10.3389/fonc.2019.01563. eCollection 2019.